| Dr Peter Joseph Musliner, MD | |
|
518 Great Road, Acton, MA 01720-3415 | |
| (978) 263-4878 | |
| (978) 635-0386 |
| Full Name | Dr Peter Joseph Musliner |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 56 Years |
| Location | 518 Great Road, Acton, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093880304 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 32511 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Professional Counseling Services Inc | 3870487333 | 8 |
News Archive
Hearing loss afflicts approximately 48 million Americans and the number is expected to increase as the population ages.
Reprieve Cardiovascular, a pioneering medical device company focused on improving outcomes for patients suffering from Acute Decompensated Heart Failure, today announced the results of two non-randomized, prospective clinical trials in patients hospitalized with Acute Heart Failure.
The United Kingdom's Human Fertilisation and Embryology Authority on Wednesday approved a policy that will allow women who donate eggs for human embryonic stem cell research to receive up to $500 for each cycle to cover costs associated with travel and lost wages, the AP/Washington Post reports
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
Radiation therapy is one of the most widely used cancer treatments, but it often damages normal tissue and can lead to debilitating conditions. A class of drugs known as mammalian target of rapamycin (mTOR) inhibitors can prevent radiation-induced tissue damage in mice by protecting normal stem cells that are crucial for tissue repair, according to a preclinical study published by Cell Press in the September issue of the journal Cell Stem Cell.
› Verified 1 days ago
| Entity Name | Professional Counseling Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477617306 PECOS PAC ID: 3870487333 Enrollment ID: O20040214000138 |
News Archive
Hearing loss afflicts approximately 48 million Americans and the number is expected to increase as the population ages.
Reprieve Cardiovascular, a pioneering medical device company focused on improving outcomes for patients suffering from Acute Decompensated Heart Failure, today announced the results of two non-randomized, prospective clinical trials in patients hospitalized with Acute Heart Failure.
The United Kingdom's Human Fertilisation and Embryology Authority on Wednesday approved a policy that will allow women who donate eggs for human embryonic stem cell research to receive up to $500 for each cycle to cover costs associated with travel and lost wages, the AP/Washington Post reports
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
Radiation therapy is one of the most widely used cancer treatments, but it often damages normal tissue and can lead to debilitating conditions. A class of drugs known as mammalian target of rapamycin (mTOR) inhibitors can prevent radiation-induced tissue damage in mice by protecting normal stem cells that are crucial for tissue repair, according to a preclinical study published by Cell Press in the September issue of the journal Cell Stem Cell.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter Joseph Musliner, MD 518 Great Road, Acton, MA 01720-3415 Ph: (978) 263-4878 | Dr Peter Joseph Musliner, MD 518 Great Road, Acton, MA 01720-3415 Ph: (978) 263-4878 |
News Archive
Hearing loss afflicts approximately 48 million Americans and the number is expected to increase as the population ages.
Reprieve Cardiovascular, a pioneering medical device company focused on improving outcomes for patients suffering from Acute Decompensated Heart Failure, today announced the results of two non-randomized, prospective clinical trials in patients hospitalized with Acute Heart Failure.
The United Kingdom's Human Fertilisation and Embryology Authority on Wednesday approved a policy that will allow women who donate eggs for human embryonic stem cell research to receive up to $500 for each cycle to cover costs associated with travel and lost wages, the AP/Washington Post reports
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that researchers at McGill Center for Studies in Aging, Douglas Research Institute and Montreal Neurological Institute presented results of a post-mortem brain tissue study using Navidea's investigational Fluorine-18 labeled β-amyloid imaging agent, NAV4694, during the Alzheimer's Association International Conference in Boston, MA.
Radiation therapy is one of the most widely used cancer treatments, but it often damages normal tissue and can lead to debilitating conditions. A class of drugs known as mammalian target of rapamycin (mTOR) inhibitors can prevent radiation-induced tissue damage in mice by protecting normal stem cells that are crucial for tissue repair, according to a preclinical study published by Cell Press in the September issue of the journal Cell Stem Cell.
› Verified 1 days ago
Dr. Derick E Vergne, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 179 Great Rd Ste 201, Acton, MA 01720 Phone: 857-239-1911 Fax: 617-544-0937 | |
Dr. Kenneth Minkoff, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 100 Powdermill Rd # 319, Acton, MA 01720 Phone: 978-502-1729 Fax: 415-455-8016 | |
Alia Goodheart, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 33 Nagog Park Ste 215, Acton, MA 01720 Phone: 508-834-3183 Fax: 508-532-1168 | |
Alison Mary Sheridan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 518 Great Rd, Acton, MA 01720 Phone: 978-263-4878 Fax: 978-635-0386 | |
Dr. Eugene Victor Beresin, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 80 School St, Acton, MA 01720 Phone: 617-726-8471 | |
Devin Gibbs, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 518 Great Rd, Acton, MA 01720 Phone: 978-263-4878 |